Diagnosing ATTR-CM: Recent Advances and Future Directions

Guest: Ronald Witteles, MD Even with growing awareness of transthyretin amyloid cardiomyopathy (ATTR-CM), delays in diagnosis remain a significant challenge. That's why Dr. Ronald Witteles, Professor of Cardiovascular Medicine at Stanford Medicine and Co-Director of the Stanford Amyloid Center, joins us to share practical strategies for recognizing ATTR-CM, implementing the appropriate diagnostic pathway, and overcoming common testing pitfalls.